[Form 4] Materion Corporation Insider Trading Activity
Rhea-AI Filing Summary
Materion Corporation (MTRN) director Robert J. Phillippy reported transactions dated 09/05/2025 showing routine compensation-related activity. He acquired 15.125 shares of common stock at a $0 price and received 2 restricted stock units (each converting to one share) credited with a $0 price after reinvestment of dividend equivalents; the RSUs vest by the earlier of May 8, 2026 or the next annual meeting. He disposed of 5,158 shares. After the reported transactions, Mr. Phillippy beneficially owned 12,002.506 shares indirectly (held in a directors' deferred compensation plan) and 2,002 shares directly related to the RSUs.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation and dividend-equivalent reinvestment; transaction sizes are modest relative to company equity.
The filing documents a typical director equity event: a small acquisition of 15.125 common shares and 2 restricted stock units arising from dividend-equivalent reinvestment, alongside a disposal of 5,158 shares. The acquisitions are recorded at a $0 price, consistent with dividend-equivalent credits rather than open-market purchases. The director retains a substantial indirect stake of 12,002.506 shares in a deferred compensation plan, indicating continued alignment with shareholder interests. No options, loans, or novel arrangements are disclosed.
TL;DR: Disclosure reflects standard director compensation mechanics and timely SEC reporting.
The Form 4 shows standard governance practices: dividend-equivalent reinvestment into RSUs that vest on a set schedule and reporting of shares held in a directors' deferred compensation plan. Vesting schedule (earlier of May 8, 2026 or next annual meeting) is explicitly stated. The filing was signed by an attorney-in-fact, consistent with routine administrative processing. There are no indications of unusual related-party transactions or change-in-control provisions disclosed in this filing.